Detalles de la búsqueda
1.
Clonal dynamics and clinical implications of postremission clonal hematopoiesis in acute myeloid leukemia.
Blood
; 138(18): 1733-1739, 2021 11 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34115096
2.
Clinical outcomes and impact of therapeutic intervention in patients with acute myeloid leukemia who experience measurable residual disease (MRD) recurrence following MRD-negative remission.
Am J Hematol
; 97(11): E408-E411, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36054774
3.
Posttransplantation cyclophosphamide improves transplantation outcomes in patients with AML/MDS who are treated with checkpoint inhibitors.
Cancer
; 126(10): 2193-2205, 2020 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32125707
4.
The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia.
Cancer
; 125(9): 1470-1481, 2019 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30500073
5.
Haploidentical transplantation for acute myeloid leukemia patients with minimal/measurable residual disease at transplantation.
Am J Hematol
; 94(12): 1382-1387, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31595538
6.
A myeloablative fractionated busulfan conditioning regimen with post-transplant cyclophosphamide in HLA-matched and haploidentical transplantation: results of a phase II study.
Haematologica
; 107(10): 2496-2500, 2022 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35770531
7.
Predictors of inferior clinical outcome in patients with standard-risk multiple myeloma.
Eur J Haematol
; 98(3): 263-268, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-27862330
8.
Optimal Threshold and Time of Absolute Lymphocyte Count Assessment for Outcome Prediction after Bone Marrow Transplantation.
Biol Blood Marrow Transplant
; 22(3): 505-13, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26524730
9.
Impact of graft composition on outcomes of haploidentical bone marrow stem cell transplantation.
Haematologica
; 106(1): 269-274, 2021 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32107328
10.
Phase II Trial of Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide after Reduced-Intensity Busulfan/Fludarabine Conditioning for Hematological Malignancies.
Biol Blood Marrow Transplant
; 21(5): 906-12, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25667989
11.
Prognostic factors influencing survival after allogeneic transplantation for AML/MDS patients with TP53 mutations.
Blood
; 131(26): 2989-2992, 2018 06 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-29769261
12.
Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen-matched unrelated and related donors.
Biol Blood Marrow Transplant
; 20(12): 1975-81, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25263628
13.
Myeloablative conditioning using timed-sequential busulfan plus fludarabine in older patients with acute myeloid leukemia: long-term results of a prospective phase II clinical trial.
Haematologica
; 104(12): e555-e557, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30948491
14.
Identification of Nonfunctional Alternatively Spliced Isoforms of STING in Human Acute Myeloid Leukemia.
Cancer Res Commun
; 4(3): 911-918, 2024 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38477596
15.
Characteristics and Outcomes of Patients With Multiple Myeloma Who Developed Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome After Autologous Cell Transplantation.
Transplant Cell Ther
; 30(2): 205.e1-205.e12, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37437764
16.
Azacitidine Post-transplant Maintenance Improves Disease Progression in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome.
Clin Lymphoma Myeloma Leuk
; 24(5): e196-e204, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38403505
17.
Targeting MCL1-driven anti-apoptotic pathways overcomes blast progression after hypomethylating agent failure in chronic myelomonocytic leukemia.
Cell Rep Med
; : 101585, 2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38781960
18.
Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis in vitro.
Biochem Pharmacol
; 220: 115981, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38081370
19.
Targeting MCL1-driven anti-apoptotic pathways to overcome hypomethylating agent resistance in RAS -mutated chronic myelomonocytic leukemia.
bioRxiv
; 2023 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37066354
20.
Impact of type of induction therapy on outcomes in older adults with AML after allogeneic stem cell transplantation.
Blood Adv
; 7(14): 3573-3581, 2023 07 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37104058